Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Redeemable Preferred Stock and Stockholders??? Equity

v3.24.3
Condensed Consolidated Statement of Redeemable Preferred Stock and Stockholders’ Equity - USD ($)
$ in Thousands
Total
Pre-Paid Advance Agreement
Standby Equity Purchase Agreement
Securities Purchase Agreement
PIPE
Sale Of Shares Under The Wainwright ATM Program
Redeemable Preferred Stock
Common stock
Common stock
Pre-Paid Advance Agreement
Common stock
Standby Equity Purchase Agreement
Common stock
PIPE
Common stock
Sale Of Shares Under The Wainwright ATM Program
Additional paid-in capital
Additional paid-in capital
Pre-Paid Advance Agreement
Additional paid-in capital
Standby Equity Purchase Agreement
Additional paid-in capital
Securities Purchase Agreement
Additional paid-in capital
PIPE
Additional paid-in capital
Sale Of Shares Under The Wainwright ATM Program
Accumulated deficit
Balance as of beginning of period (in shares) at Dec. 31, 2022             0                        
Balance as of beginning of period (in shares) at Dec. 31, 2022 [1]               15,452,000                      
Balance as of beginning of period at Dec. 31, 2022 $ 236,573           $ 0 $ 2 [1]         $ 1,416,394 [1]           $ (1,179,823)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Repurchase of unvested shares – forfeitures (in shares) [1]               (1,000)                      
Issuance of shares for restricted stock units vested (in shares) [1]               120,000                      
Issuance of shares under employee stock purchase plan (in shares) [1]               30,000                      
Issuance of shares under employee stock purchase plan 389                       389 [1]            
Vesting of early exercised stock options and restricted stock awards 26                       26 [1]            
Issuance of shares under the PPA and SPA, net of offering costs (in shares) [1]                 2,903,000 2,174,000                  
Issuance of shares under the PPA, SPA , ATM, SEPA and PIPE   $ 64,389 $ 10,161 $ 1,600                   $ 64,389 [1] $ 10,161 [1] $ 1,600 [1]      
Reclassification of warrant liability to additional paid-in capital 19,510                       19,510 [1]            
Stock-based compensation 9,836                       9,836 [1]            
Net income (loss) (90,732)                                   (90,732)
Comprehensive income (loss) (90,732)                                   (90,732)
Balance as of end of period (in shares) at Mar. 31, 2023             0                        
Balance at the end of the period (in shares) at Mar. 31, 2023 [1]               20,678,000                      
Balance as of end of period at Mar. 31, 2023 251,752           $ 0 $ 2 [1]         1,522,305 [1]           (1,270,555)
Balance as of beginning of period (in shares) at Dec. 31, 2022             0                        
Balance as of beginning of period (in shares) at Dec. 31, 2022 [1]               15,452,000                      
Balance as of beginning of period at Dec. 31, 2022 236,573           $ 0 $ 2 [1]         1,416,394 [1]           (1,179,823)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net income (loss) (273,576)                                    
Comprehensive income (loss) (273,576)                                    
Balance as of end of period (in shares) at Sep. 30, 2023             0                        
Balance at the end of the period (in shares) at Sep. 30, 2023 [1]               28,300,000                      
Balance as of end of period at Sep. 30, 2023 165,652           $ 0 $ 2 [1]         1,619,049 [1]           (1,453,399)
Balance as of beginning of period (in shares) at Mar. 31, 2023             0                        
Balance as of beginning of period (in shares) at Mar. 31, 2023 [1]               20,678,000                      
Balance as of beginning of period at Mar. 31, 2023 251,752           $ 0 $ 2 [1]         1,522,305 [1]           (1,270,555)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Repurchase of unvested shares – forfeitures (in shares) [1]               (1,000)                      
Repurchase of unvested shares - forfeitures 0                       0 [1]            
Issuance of shares for restricted stock units vested (in shares) [1]               88,000                      
Issuance of shares under employee stock purchase plan (in shares) [1]               26,000                      
Issuance of shares under employee stock purchase plan 246                       246 [1]            
Vesting of early exercised stock options and restricted stock awards     2                       2 [1]        
Issuance of shares under the PPA and SPA, net of offering costs (in shares) [1]                     710,000 83,000              
Issuance of shares under the PPA, SPA , ATM, SEPA and PIPE         $ 1,753 $ 1,155         $ 0 [1]           $ 1,753 [1] $ 1,155 [1]  
Proceeds from exercise of YA warrants (in shares) [1]               1,488,000                      
Proceeds from exercise of YA warrants 21,223                       21,223 [1]            
Issuance of shares under YA convertible debenture (in shares) [1]               1,552,000                      
Issuance of shares under YA convertible debenture 19,021                       19,021 [1]            
Issuance of shares under I-40 financing arrangement (in shares) [1]               101,000                      
Issuance of shares under I-40 financing arrangement 1,506                       1,506 [1]            
Issuance of shares to vendor for services (in shares) [1]               9,000                      
Issuance of shares to vendor for services 250                       250 [1]            
Stock-based compensation 6,707                       6,707 [1]            
Net income (loss) (70,870)                                   (70,870)
Comprehensive income (loss) (70,870)                                   (70,870)
Balance as of end of period (in shares) at Jun. 30, 2023             0                        
Balance at the end of the period (in shares) at Jun. 30, 2023 [1]               24,735,000                      
Balance as of end of period at Jun. 30, 2023 232,745           $ 0 $ 2 [1]         1,574,168 [1]           (1,341,425)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Repurchase of unvested shares – forfeitures (in shares) [1]               (1,000)                      
Repurchase of unvested shares - forfeitures 0                                    
Issuance of shares for restricted stock units vested (in shares) [1]               48,000                      
Issuance of shares for restricted stock units vested 0                                    
Issuance of shares upon exercise of vested stock options 0                                    
Issuance of shares under employee stock purchase plan (in shares) [1]               24,000                      
Issuance of shares under employee stock purchase plan 231                       231 [1]            
Vesting of early exercised stock options and restricted stock awards 2                       2 [1]            
Issuance of shares under the PPA and SPA, net of offering costs (in shares) [1]                 654,000   243,000                
Issuance of shares under the PPA, SPA , ATM, SEPA and PIPE   7,523     19                 7,523 [1]     19 [1]    
Issuance of shares under YA convertible debenture (in shares) [1]               2,598,000                      
Issuance of shares under YA convertible debenture 30,198                       30,198 [1]            
Stock-based compensation 6,908                       6,908 [1]            
Net income (loss) (111,974)                                   (111,974)
Comprehensive income (loss) (111,974)                                   (111,974)
Balance as of end of period (in shares) at Sep. 30, 2023             0                        
Balance at the end of the period (in shares) at Sep. 30, 2023 [1]               28,300,000                      
Balance as of end of period at Sep. 30, 2023 $ 165,652           $ 0 $ 2 [1]         1,619,049 [1]           (1,453,399)
Balance as of beginning of period (in shares) at Dec. 31, 2023 45,000           45,000                        
Balance as of beginning of period (in shares) at Dec. 31, 2023 37,591,000             37,591,000 [2]                      
Balance as of beginning of period at Dec. 31, 2023 $ 249,576           $ 5,607 $ 4 [2]         1,725,809 [2]           (1,481,844)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Issuance of shares for restricted stock units vested (in shares) [2]               1,892,000                      
Issuance of shares for restricted stock units vested 0                                    
Issuance of shares under employee stock purchase plan (in shares) [2]               26,000                      
Issuance of shares under employee stock purchase plan 79                       79 [2]            
Issuance of shares under the PPA and SPA, net of offering costs (in shares) [2]                 21,935,000 290,000                  
Issuance of shares under the PPA, SPA , ATM, SEPA and PIPE   54,940 $ 562           $ 2 [2]         54,938 [2] $ 562 [2]        
Issuance of shares under YA convertible debenture (in shares) [2]                 4,672,000                    
Issuance of shares under YA convertible debenture   $ 22,254                       $ 22,254 [2]          
Exchange of YA warrants (43,416)                       (43,416) [2]            
Accretion of preferred shares 0           $ 862           (862) [2]            
Stock-based compensation 10,954                       10,954 [2]            
Net income (loss) (110,687)                                   (110,687)
Comprehensive income (loss) (110,687)                                   (110,687)
Balance as of end of period (in shares) at Mar. 31, 2024             45,000                        
Balance at the end of the period (in shares) at Mar. 31, 2024 [2]               66,406,000                      
Balance as of end of period at Mar. 31, 2024 $ 184,262           $ 6,469 $ 6 [2]         1,770,318 [2]           (1,592,531)
Balance as of beginning of period (in shares) at Dec. 31, 2023 45,000           45,000                        
Balance as of beginning of period (in shares) at Dec. 31, 2023 37,591,000             37,591,000 [2]                      
Balance as of beginning of period at Dec. 31, 2023 $ 249,576           $ 5,607 $ 4 [2]         1,725,809 [2]           (1,481,844)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Issuance of shares under the PPA, SPA , ATM, SEPA and PIPE                               $ 1,600      
Net income (loss) (112,389)                                    
Comprehensive income (loss) $ (112,389)                                    
Balance as of end of period (in shares) at Sep. 30, 2024 62,000                                    
Balance at the end of the period (in shares) at Sep. 30, 2024 87,195,000             87,195,000 [2]                      
Balance as of end of period at Sep. 30, 2024 $ 221,959           $ 8,780 $ 9 [2]         1,807,403 [2]           (1,594,233)
Balance as of beginning of period (in shares) at Mar. 31, 2024             45,000                        
Balance as of beginning of period (in shares) at Mar. 31, 2024 [2]               66,406,000                      
Balance as of beginning of period at Mar. 31, 2024 184,262           $ 6,469 $ 6 [2]         1,770,318 [2]           (1,592,531)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Issuance of shares for restricted stock units vested (in shares) [2]               111,000                      
Issuance of shares for restricted stock units vested 0                                    
Issuance of shares under employee stock purchase plan (in shares) [2]               20,000                      
Issuance of shares under employee stock purchase plan 35                       35 [2]            
Issuance of shares under the PPA and SPA, net of offering costs (in shares) [2]                     6,291,000                
Issuance of shares under the PPA, SPA , ATM, SEPA and PIPE         15,607           $ 1 [2]           15,606 [2]    
Issuance of shares under YA convertible debenture (in shares)             17,000                        
Accretion of preferred shares 0           $ 1,077           (1,077) [2]            
Issuance of shares to vendor for services (in shares) [2]               74,000                      
Issuance of shares to vendor for services 225                       225 [2]            
Stock-based compensation 1,128                       1,128 [2]            
Net income (loss) (4,960)                                   (4,960)
Comprehensive income (loss) (4,960)                                   (4,960)
Balance as of end of period (in shares) at Jun. 30, 2024             62,000                        
Balance at the end of the period (in shares) at Jun. 30, 2024 [2]               72,902,000                      
Balance as of end of period at Jun. 30, 2024 196,297           $ 7,546 $ 7 [2]         1,786,235 [2]           (1,597,491)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Issuance of shares for restricted stock units vested (in shares) [2]               666,000                      
Issuance of shares for restricted stock units vested 0                                    
Issuance of shares under employee stock purchase plan (in shares) [2]               17,000                      
Issuance of shares under employee stock purchase plan 14                       14 [2]            
Issuance of shares under the PPA and SPA, net of offering costs (in shares) [2]                     9,796,000 3,725,000              
Issuance of shares under the PPA, SPA , ATM, SEPA and PIPE         $ 16,872 $ 3,681         $ 2 [2]           $ 16,870 [2] $ 3,681 [2]  
Accretion of preferred shares 0           1,234           (1,234)            
Issuance of shares to vendor for services (in shares) [2]               89,000                      
Issuance of shares to vendor for services 190                       190 [2]            
Stock-based compensation 1,647                       1,647 [2]            
Net income (loss) 3,258                                    
Comprehensive income (loss) $ 3,258                                    
Balance as of end of period (in shares) at Sep. 30, 2024 62,000                                    
Balance at the end of the period (in shares) at Sep. 30, 2024 87,195,000             87,195,000 [2]                      
Balance as of end of period at Sep. 30, 2024 $ 221,959           $ 8,780 $ 9 [2]         $ 1,807,403 [2]           $ (1,594,233)
[1] Periods presented have been adjusted to reflect the 1-for-23 reverse stock split on March 8, 2024. See Note 1- Organization and Basis of Presentation - Reverse Stock Split, for additional information.
[2] Periods presented have been adjusted to reflect the 1-for-23 reverse stock split on March 8, 2024. See Note 1- Organization and Basis of Presentation - Reverse Stock Split, for additional information.